Bortenat 3.5 Mg Bortezomib Injection

₹2,484.00

Specification

brand: Bortenat 3.5mg
marketer: Natco Pharma Ltd
strength: 3.5 mg
treatment: Treatment of Cancer
shelf life: 24 Months
composition: Bortezomib (3.5mg)
availability: In Stock
packaging type: Vial
country of origin: Made in India

Add Quantity

Response within 4 hoursTo enquire

Description

Bortenat 3.5mg Injection is used in the treatment of multiple myeloma and mantle-cell lymphoma. It shows its working by stopping or slowing down the growth of cancer cells.

Verify supplier credentials before transacting. Enquiries create leads for the supplier.